Literature DB >> 12229885

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.

Michele Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini, Michele Cini, Lelia Valdrè, Gualtiero Palareti, Luciano Masini, Sante Tura, Michele Baccarani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12229885     DOI： 10.1182/blood-2002-06-1674

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

Review 1.  Cancer, clots and consensus: new understanding of an old problem.

Authors:  Gary H Lyman; Alok A Khorana
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

2.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

Review 3.  Guidelines for treatment and prevention of venous thromboembolism among patients with cancer.

Authors:  Nicole M Kuderer; Gary H Lyman
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

4.  Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.

Authors:  Nicholas G Theodorakis; Yining N Wang; Vyacheslav A Korshunov; Mary A Maluccio; Nicholas J Skill
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Effect of Huisheng oral solution on coagulation function in perioperative period in patients with primary lung cancer.

Authors:  Xiaoguang Yang; Helin Zhang; Fanyi Kong; Guochen Wang; Qianyu Gu; Zheng Zhao; Tiezhi Li; Mingming Ren; Zuosheng Li; Yang Guo
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Thromboembolic events with lenalidomide-based therapy for multiple myeloma.

Authors:  Smitha Patiyil Menon; S Vincent Rajkumar; Martha Lacy; Patrizia Falco; Antonio Palumbo
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

Review 7.  Venous thromboembolism and prognosis in cancer.

Authors:  Alok A Khorana
Journal:  Thromb Res       Date:  2010-01-25       Impact factor: 3.944

8.  Pulmonary embolism in a patient with multiple myeloma receiving thalidomide-dexamethasone therapy.

Authors:  Wen-Juei Jeng; Ming-Chung Kuo; Lee-Yung Shih; Pao-Hsien Chu
Journal:  Int J Hematol       Date:  2008-04-15       Impact factor: 2.490

9.  Idiopathic and recurrent thromboembolic phenomena in cancer patients.

Authors:  Miriam López-Gómez; César Gómez-Raposo; María Sereno Moyano; Enrique Casado-Sáenz; Jaime Feliú Batlle; Carolina Ortega Ruipérez; Manuel González Barón
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

Review 10.  New therapies in multiple myeloma.

Authors:  F Merchionne; F Perosa; F Dammacco
Journal:  Clin Exp Med       Date:  2007-10-03       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.